Searched for
SAHAJANAND MEDICAL TECHNOLOGIES
Ashish Kacholia and Samara Capital backed Sahajanand Medical Technologies files DRHP for IPOSahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. ...
SMT appoints Bhargav Kotadia as chief executive officerSamara Capital-backed Sahajanand Medical Technologies has named Bhargav Kotadia as CEO and Jose Calle Gordo (‘Pepe’) as chairman, effective...
Sahajanand Medical Technologies prepares for market debut with Rs 2,000 crore IPOMumbai-based stent manufacturer Sahajanand Medical Technologies is planning to raise up to ₹2,000 crore through an IPO, aiming to fuel glob...
Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...
Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
Five years on, Morgan Stanley PE to exit cardiac stent maker SMTExisting investor Samara Capital and the promoter, Dhirajlal Kotadia and his family, are also likely to sell an about 15-20% stake between ...
Mandaviya urges industry to boost local production of medical devicesMandaviya urged industry participants to make concrete efforts toward increasing the localisation impact and deepen the domestic manufactur...
Ixigo, Sahajanand Medical Tech, Keventer Agro get Sebi's go-ahead to float IPOsThese three companies, which filed their preliminary IPO papers with Sebi between August and September, obtained observation letter from th...
Sahajanand Medical Technologies files draft paper for Rs 1500 cr IPOThe company plans to raise Rs 1,500 crore through an initial public offering (IPO) through a fresh issue of shares, aggregating up to Rs 41...
Stent maker Sahajanand Medical Tech files IPO papers with SebiThe company may consider a pre-IPO placement of equity shares aggregating up to Rs 185 crore. If such placement is undertaken, the fresh is...
Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuationEstablished in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (...
Dassault Systèmes demonstrates innovations for the life sciences industry in IndiaThe event focused on transforming and digitalizing the life sciences industry in India, which is undergoing core shifts in business process...
Everstone picks up minority stake in stent company TransluminaDeal worth Rs 500 crore to help Indian stent maker acquire global assets, boost R&D efforts
SMT bags tender to supply 10,000 stents to Italian public hospitalsEmilia Romagna is one of the most populous regions of north Italy, with 15 cath labs performing 10% of Italian Percutaneous Coronary Interv...
No shortage of stents in the country: NPPAThe National Pharmaceutical Pricing Authority (NPPA) met stent makers and importers today to discuss issues like pricing and availability o...
Samara Capital buys stake in SMTAs part of the deal, Samara Capital's managing director Gautam Gode and vice president Abhishek Kabra will come on SMT's board.
SMT to conduct quality trials of its stents in EuropeThe company will test the quality, safety and efficacy of 86 variations of Supraflex stents against their Xience equivalents between now an...
Surat captures 30% share of cardiac stents market in India, becomes largest manufacturerSurat, famed for its Rs 90,000 crore diamond industry, has emerged as the biggest manufacturer of cardiac stents in India.
- Indust-real achievements
As India's corporate sharks continue to climb notches above the Global power list of Rich and Influential, the real engines of success have...
- Surat's diamond industry gets a makeover
Surat’s diamond industry gets a facelift, thanks to Sahajanand’s laser cutting machine, the first of its kind in India.